Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 104455
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104455
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104455
Table 1 Comparison of features between cardia and non-cardia gastric adenocarcinoma, mean ± SD/n (%)
Characteristic | PGC (n = 84) | DGC (n = 66) | Total (n = 150) | P value |
Age | 65.3 ± 11.0 | 67.7 ± 9.5 | 66.4 ± 10.4 | 0.164 |
Gender | 0.005 | |||
Female | 39 (46) | 16 (24) | 55 (37) | |
Male | 45 (54) | 50 (76) | 95 (63) | |
Observation duration (mo) | 23.8 ± 14.4 | 22.7 ± 12.9 | 23.3 ± 13.7 | 0.916 |
Complaint at admission | ||||
Dyspepsia | 47 (56) | 44 (67) | 91 (61) | 0.182 |
Bleeding | 19 (23) | 15 (23) | 34 (23) | 0.987 |
Constitutional | 7 (8) | 7 (11) | 14 (9) | 0.935 |
Dysphagia | 21 (25) | 0 (0) | 21 (14) | < 0.001 |
Anemia | 10 (12) | 16 (24) | 26 (17) | 0.048 |
Comorbidities | ||||
HT | 30 (36) | 22 (33) | 52 (35) | 0.761 |
DM | 13 (16) | 8 (12) | 21 (14) | 0.556 |
Cardiovascular | 20 (24) | 11 (17) | 31 (21) | 0.284 |
AF | 3 (4) | 0 (0) | 3 (2) | 0.256 |
CRD | 10 (12) | 9 (14) | 19 (13) | 0.752 |
CVD | 2 (2) | 4 (6) | 6 (4) | 0.406 |
CRF | 3 (4) | 1 (2) | 4 (3) | 0.631 |
Hypothyroidism | 4 (5) | 0 (0) | 4 (3) | 0.131 |
Stage | 0.525 | |||
1 | 6 (8) | 5 (9) | 11 (8) | |
2 | 5 (7) | 8 (14) | 3 (10) | |
3 | 33 (45) | 21 (36) | 54 (41) | |
4 | 29 (40) | 24 (41) | 53 (41) | |
Metastasis | 31 (40) | 24 (36) | 55 (37) | 0.946 |
Laboratory tests | ||||
WBC, 103/UL | 8.6 ± 3.3 | 8.1 ± 3.4 | 8.3 ± 3.4 | 0.246 |
Neutrophils, 103/UL | 5.6 ± 2.2 | 5.6 ± 3.2 | 5.6 ± 2.7 | 0.473 |
Lym, 103/UL | 2.1 ± 0.9 | 1.8 ± 0.7 | 1.9 ± 0.8 | 0.084 |
Monocytes, 103/UL | 0.5 ± 0.2 | 0.5 ± 0.2 | 0.5 ± 0.2 | 0.454 |
Hemoglobin, g/dL | 12.5 ± 2.7 | 11.9 ± 2.9 | 12.2 ± 2.8 | 0.192 |
RDW, % | 15.2 ± 3.7 | 15.9 ± 3.4 | 15.5 ± 3.6 | 0.134 |
Platelet, 103/UL | 293 ± 113 | 308 ± 125 | 299 ± 117 | 0.429 |
MPV, fL | 9.5 ± 1.1 | 9.5 ± 1.1 | 9.5 ± 1.1 | 0.892 |
PDW, % | 16.1 ± 0.4 | 15.9 ± 0.4 | 16.0 ± 0.4 | 0.623 |
CRP, mg/L | 18.7 ± 26.8 | 18.1 ± 29.1 | 18.4 ± 27.8 | 0.920 |
Albumin, g/dL | 3.8 ± 0.5 | 3.7 ± 5.7 | 3.7 ± 5.3 | 0.486 |
AST, IU/L | 22.8 ± 15.2 | 19.6 ± 11.6 | 21.4 ± 13.7 | 0.177 |
ALT, IU/L | 18.6 ± 15.9 | 17.1 ± 14.9 | 17.9 ± 15.5 | 0.539 |
Total bilirubin, mg/dL | 0.6 ± 0.4 | 0.6 ± 0.5 | 0.6 ± 0.4 | 0.442 |
Creatinine, mg/dL | 0.82 ± 0.28 | 0.83 ± 0.24 | 0.83 ± 0.26 | 0.589 |
BUN, mg/dL | 40.9 ± 17.9 | 43.5 ± 28.5 | 42.1 ± 23.1 | 0.768 |
Sodium, mEq/L | 138.2 ± 3.4 | 138.1 ± 2.9 | 138.1 ± 3.2 | 0.953 |
Potassium, mEq/L | 4.2 ± 0.5 | 4.3 ± 0.5 | 4.2 ± 0.5 | 0.457 |
Index | ||||
NLR | 2.9 ± 2.1 | 3.8 ± 3.7 | 3.3 ± 2.9 | 0.413 |
PLR | 157.3 ± 91.5 | 191.2 ± 115.2 | 172.2 ± 103.6 | 0.031 |
LMR | 8.8 ± 39.5 | 4.1 ± 2.1 | 6.7 ± 29.6 | 0.311 |
SII | 897 ± 705 | 1316 ± 1856 | 1081 ± 1350 | 0.401 |
Death | 15 (18) | 12 (18) | 27 (18) | 0.959 |
- Citation: Dolu S, Cengiz MB, Döngelli H, Gürbüz M, Arayici ME. Importance of hematological and inflammatory markers in the localization of gastric cancer. World J Gastrointest Oncol 2025; 17(4): 104455
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/104455.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.104455